New bacteria discovery could help treat noma deadly childhood

Published: 25 April 2026. The English Chronicle Desk. The English Chronicle Online

A groundbreaking scientific discovery is offering fresh hope in the fight against Noma, a devastating and often fatal condition that primarily affects young children living in extreme poverty.

Researchers have identified a previously unknown species of bacteria that may play a crucial role in the development of the disease, potentially opening the door to earlier detection and more targeted treatments. The findings are being described by experts as “astonishing” and could mark a turning point in understanding a condition that has long puzzled the global health community.

Noma, sometimes referred to as the “face of poverty,” begins as a relatively minor infection in the gums but can rapidly escalate into a severe condition that destroys soft tissue in the mouth and face. Without treatment, the disease has a mortality rate of up to 90 percent. Survivors are often left with lifelong disfigurement and face significant social stigma.

The condition is most commonly reported in parts of the Sahel region in Africa, though cases have been documented elsewhere. It is closely linked to malnutrition, poor hygiene, and limited access to healthcare, making it one of the most neglected tropical diseases globally.

The new research, led by the Liverpool School of Tropical Medicine, focused on analysing the bacterial communities present in the mouths of children affected by noma. Scientists collected samples from patients in Nigeria and used advanced genetic sequencing techniques to study the microbial environment.

Their analysis revealed a striking imbalance in oral bacteria among noma patients. Healthy bacterial species were found to be significantly reduced, while other, potentially harmful microbes were present in much higher numbers. Among these, researchers identified a previously unknown strain of Treponema, now provisionally named Treponema A.

The discovery has generated considerable excitement among scientists. Professor Adam Roberts, one of the senior researchers involved in the study, described the moment the findings were presented as a “great reveal,” noting the significance of identifying a consistent bacterial presence across multiple patient samples.

However, researchers caution that much remains unknown. It is not yet clear whether Treponema A directly causes noma or whether it thrives in the unique conditions created by the disease. Determining this relationship will be a key focus of future studies, which are expected to involve larger sample sizes and comparisons with healthy individuals in affected communities.

Despite these uncertainties, the implications of the discovery are far-reaching. If a strong causal link is established, it could lead to the development of diagnostic tests capable of identifying children at risk before the disease progresses to its most destructive stage.

Currently, noma is diagnosed based on visible symptoms, often when the disease has already caused significant damage. Early detection tools could allow healthcare providers to intervene much sooner, using targeted antibiotic treatments to halt progression and save lives.

The findings also raise the possibility of more precise therapies. At present, noma is treated with broad-spectrum antibiotics, which can be effective but may contribute to the growing global problem of antimicrobial resistance. A treatment specifically targeting the bacteria involved in noma could reduce this risk while improving outcomes.

Researchers have also highlighted the potential role of probiotics in restoring healthy bacterial balance in the mouth, offering another possible avenue for prevention. Such approaches could be particularly valuable in resource-limited settings where access to advanced medical care is restricted.

The study, published in the journal PLoS Neglected Tropical Diseases, involved collaboration between multiple institutions, including the University of Liverpool, Médecins Sans Frontières and a specialised noma treatment centre in Nigeria.

Experts not involved in the research have welcomed the findings as an important step forward. Dr Michael Head, a global health researcher, noted that while the discovery does not yet provide definitive answers, it represents significant progress in understanding a disease that has remained largely unexplained for decades.

The identification of a new Treponema species is particularly notable given that other members of this bacterial group are known to cause serious infections, including syphilis. This connection underscores the importance of further investigation into how such bacteria interact with human tissues and immune responses.

Global health specialists have long argued that noma receives far less attention and funding than other diseases with comparable mortality rates. The new findings could help draw greater interest from researchers and policymakers, potentially leading to increased investment in prevention and treatment efforts.

For affected communities, the stakes are high. Noma not only threatens lives but also carries profound social consequences, with survivors often facing isolation and discrimination due to visible facial damage.

By shedding light on the biological mechanisms behind the disease, the discovery of Treponema A offers a rare sense of optimism. While much work remains to be done, researchers believe it could ultimately lead to practical solutions that save lives and reduce suffering.

As studies continue, the hope is that this breakthrough will transform noma from a neglected and poorly understood condition into one that can be effectively prevented, diagnosed and treated—changing the future for thousands of vulnerable children worldwide.